Power Metallic Mines Inc., formerly Power Nickel Inc., is entering 2026 with one of the most compelling polymetallic and critical-minerals narratives in the junior mining sector. The company’s evolution reflects…
American Lithium Minerals (OTCID: AMLM) continues to reposition itself as a diversified, U.S.-anchored critical minerals company as it advances a series of mineral acquisitions spanning North America, South America, and…
In a market increasingly driven by speed, convenience, and consumer compliance, one delivery technology is quietly re-emerging as a potential breakout theme: oral thin film delivery. At the center of…
Nika Pharmaceuticals, Inc. (OTCQB: NIKA) is drawing increased investor and healthcare-industry attention following a featured interview with CEO Dimitar Savov on The Street Reports Podcast. During the discussion, Savov outlined…
ENDRA Life Sciences (NASDAQ: NDRA), a pioneer in next-generation medical imaging for the early detection and monitoring of liver disease, is redefining strategic finance for public companies through an innovative…
Aprea Therapeutics (Nasdaq: APRE), a clinical-stage oncology company developing targeted cancer therapies, reported strong third quarter results and highlighted progress in two key drug programs aimed at treating solid tumors…
Karbon-X Corp. (OTCQX: KARX) is fast emerging as one of the most dynamic growth stories in the global carbon markets, building on a series of transformational milestones that position the…
CS Diagnostics Corp. (OTCQB: CSDX), a medical technology company developing advanced diagnostic, wellness, and pharmaceutical solutions, has taken two transformative steps that strengthen its balance sheet, unify its affiliates, and…
Signal Advance, Inc. (OTC: SIGL) President and CEO Dr. Chris M. Hymel joined The Street Reports Podcast to discuss the company’s groundbreaking Analog Guard® platform — a physics-based cybersecurity technology…
Nika Pharmaceuticals, Inc. (OTCQB: NIKA), a next-generation biopharmaceutical company focused on immune-strengthening therapeutics, is emerging as a compelling investment opportunity in the global fight against HIV/AIDS, Hepatitis B and C,…
